Adaptive Biotechnologies to present at major healthcare investor conferences in Nov-Dec 2026

Adaptive Biotechnologies, a biotech company focused on immune system genetics, announced participation in two upcoming investor conferences: the Jefferies Global Healthcare Conference in London on November 18, 2026, and the Piper Sandler Healthcare Conference in New York on December 2, 2026. These events will feature presentations and a fireside chat, providing updates on the company's progress in developing immune-driven clinical products for diseases like cancer and autoimmune disorders. Investors can access live and archived webcasts on the company's website. This participation highlights Adaptive's ongoing efforts to engage with investors and showcase its innovative diagnostic and therapeutic technologies.

Adaptive Biotechnologies shares are trading at USD 29.38 on Pluang, down 2.91% in the past day. As of Nov 11, 2026 04:02 WIB, the stock shows strong buying interest with 98% of orders as buys and a market cap of $4.90 billion.